Projects
MMGH/Carsten Mantel
2019
—
Ongoing
Measles and Rubella Strategic Framework 2021-2030
MMGH is supporting the Measles & Rubella Initiative (M&RI) in the definition of the post-2020 global strategic framework in alignment with the Immunization Agenda 2030 (IA2030). After performing a situational ...
Client:
Measles and Rubella Initiative
Akiko Harayama
2020
—
Ongoing
Definition of prioritised research agenda to support the implementation of the Ending Cholera: A Global Roadmap to 2030 Strategy
In collaboration with the Global Task Force on Cholera Control (GTFCC), Wellcome Trust and MMGH are developing a prioritised research agenda with the goal of linking country-level needs with planned research ...
Client:
Wellcome Trust
CDC
2020
—
Ongoing
Definition of barriers and drivers of an effective vaccine development ecosystem
MMGH is supporting the Wellcome Trust in mapping and sizing the key drivers influencing vaccine developers’ decisions in progressing along the development pathway from transition into Phase II clinical ...
Client:
Wellcome Trust
2019
—
2019
Redesign of the Eliminate Yellow Fever programme governance and work plan
MMGH supported the Eliminate Yellow Fever (EYE) Secretariat at WHO in streamlining programme governance and defining the general lines of action to serve as the foundation of a three-year multi-agency ...
Client:
World Health Organization (WHO)
2020
—
Ongoing
Development of European Region 2030 Vaccine Action Plan
MMGH is supporting the WHO European Regional Office (EURO) in developing the Regional Immunization Agenda for the period 2021-2030 in alignment with the Global Immunization Agenda 2030 (IA2030). The Regional ...
Client:
World Health Organization (WHO)
2019
—
2019
Human Papillomavirus (HPV) affordability analysis
MMGH supported the WHO Department of Immunisation and Biologicals (IVB) in defining a logical framework to assess the barriers to access human papillomavirus (HPV) vaccine in middle-income countries, with ...
Client:
World Health Organization (WHO)